Similar articles for PMID: 28209907

Year	Number of Results
1892	1
1893	2
1894	5
1895	3
1896	1
1984	1
1985	1
1986	1
1989	1
1993	1
1998	1
1999	4
2000	1
2001	2
2003	1
2004	3
2005	3
2006	2
2007	2
2008	7
2009	5
2010	9
2011	9
2012	7
2013	14
2014	16
2015	17
2016	27
2017	29
2018	28
2019	39
2020	31
2021	36
2022	36
2023	30
2024	23
2025	3

1

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging.

Zhang-Yin J, Dirand AS, Sasanelli M, Corrégé G, Peudon A, Kiffel T, Nataf V, Clerc J, Montravers F, Talbot JN. Zhang-Yin J, et al. J Nucl Med. 2017 Aug;58(8):1230-1235. doi: 10.2967/jnumed.116.187138. Epub 2017 Feb 16. J Nucl Med. 2017. PMID: 28209907 Free article.

2

Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.

Van Binnebeek S, Vanbilloen B, Baete K, Terwinghe C, Koole M, Mottaghy FM, Clement PM, Mortelmans L, Bogaerts K, Haustermans K, Nackaerts K, Van Cutsem E, Verslype C, Verbruggen A, Deroose CM. Van Binnebeek S, et al. Eur Radiol. 2016 Mar;26(3):900-9. doi: 10.1007/s00330-015-3882-1. Epub 2015 Jul 12. Eur Radiol. 2016. PMID: 26162577 Clinical Trial.

3

⁹⁰Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.

Menda Y, Madsen MT, O'Dorisio TM, Sunderland JJ, Watkins GL, Dillon JS, Mott SL, Schultz MK, Zamba GKD, Bushnell DL, O'Dorisio MS. Menda Y, et al. J Nucl Med. 2018 Nov;59(11):1692-1698. doi: 10.2967/jnumed.117.202903. Epub 2018 Mar 9. J Nucl Med. 2018. PMID: 29523629 Free PMC article. Clinical Trial.

4

Intraindividual comparison of ¹⁸ F-FDOPA and ⁶⁸ Ga-DOTATOC PET/CT detection rate for metastatic assessment in patients with ileal neuroendocrine tumours.

Ouvrard E, Chevalier E, Addeo P, Sahakian N, Detour J, Goichot B, Bachellier P, Karcher G, Taïeb D, Imperiale A. Ouvrard E, et al. Clin Endocrinol (Oxf). 2021 Jan;94(1):66-73. doi: 10.1111/cen.14312. Epub 2020 Sep 15. Clin Endocrinol (Oxf). 2021. PMID: 32790887

5

⁶⁸Ga-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with ¹⁸F-DOPA PET/CT and ¹²³I-MIBG SPECT/CT.

Kroiss AS, Uprimny C, Shulkin BL, Gruber L, Frech A, Url C, Riechelmann H, Sprinzl GM, Thomé C, Treglia G, Kjaer A, Fraedrich G, Virgolini IJ. Kroiss AS, et al. Nucl Med Biol. 2019 Apr;71:47-53. doi: 10.1016/j.nucmedbio.2019.04.003. Epub 2019 Apr 29. Nucl Med Biol. 2019. PMID: 31152973

6

Head-to-Head Comparison of ⁶⁴Cu-DOTATATE and ⁶⁸Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors.

Johnbeck CB, Knigge U, Loft A, Berthelsen AK, Mortensen J, Oturai P, Langer SW, Elema DR, Kjaer A. Johnbeck CB, et al. J Nucl Med. 2017 Mar;58(3):451-457. doi: 10.2967/jnumed.116.180430. Epub 2016 Sep 22. J Nucl Med. 2017. PMID: 27660147 Free article. Clinical Trial.

7

Biodistribution and radiation dose estimates for ⁶⁸Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors.

Krebs S, Pandit-Taskar N, Reidy D, Beattie BJ, Lyashchenko SK, Lewis JS, Bodei L, Weber WA, O'Donoghue JA. Krebs S, et al. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):677-685. doi: 10.1007/s00259-018-4193-y. Epub 2018 Oct 29. Eur J Nucl Med Mol Imaging. 2019. PMID: 30374529 Free PMC article. Clinical Trial.

8

18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.

Balogova S, Talbot JN, Nataf V, Michaud L, Huchet V, Kerrou K, Montravers F. Balogova S, et al. Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):943-66. doi: 10.1007/s00259-013-2342-x. Epub 2013 Feb 16. Eur J Nucl Med Mol Imaging. 2013. PMID: 23417499 Free PMC article. Review.

9

The Added Diagnostic Value of ¹⁸F-Fluorodihydroxyphenylalanine PET/CT in the Preoperative Work-Up of Small Bowel Neuroendocrine Tumors.

Addeo P, Poncet G, Goichot B, Leclerc L, Brigand C, Mutter D, Romain B, Namer IJ, Bachellier P, Imperiale A. Addeo P, et al. J Gastrointest Surg. 2018 Apr;22(4):722-730. doi: 10.1007/s11605-017-3645-1. Epub 2017 Dec 12. J Gastrointest Surg. 2018. PMID: 29235002

10

Patient external dose rate after ¹⁷⁷Lu-DOTATATE therapy: factors affecting its decrease and predictive value.

Zhang-Yin J, Guilabert N, Kiffel T, Montravers F, Calais P, Lumbroso J, Talbot JN. Zhang-Yin J, et al. Int J Med Sci. 2021 May 17;18(12):2725-2735. doi: 10.7150/ijms.58680. eCollection 2021. Int J Med Sci. 2021. PMID: 34104105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 28209907

352 results

Results by year